Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    6685237 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
2 Recruiting Self-Management Program Based on Physical Exercises in People With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Other: Physical exercises in an self-management setting;   Other: Relaxation
3 Enrolling by invitation Effects of Acthar on Recovery From Cognitive Relapses in MS
Condition: Multiple Sclerosis
Intervention: Drug: Adrenocorticotropic Hormone
4 Recruiting Protective Role of Oxcarbazepine in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Oxcarbazepine;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.